Lobitaña, Santiago A.

HRN: 22-64-11  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2023
02/28/2023
IV
600mg
TID
Erysipelas
Waiting Final Action 
02/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/27/2023
03/05/2023
IVT
4.5gm
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: